Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity

World Journal of Gastroenterology

Volumn 18, Issue 10, 2012, Pages 1021-1027

  Vanella, Serafino ^a   Brisinda, Giuseppe ^a   Marniga, Gaia ^a   Crocco, Anna ^a   Bianco, Giuseppe ^a   Maria, Giorgio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Anal diseases; Anal fissure; Bariatric surgery; Biliopancreatic diversion; Botulinum toxin; Severe obesity

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ANUS FISSURE; ARTICLE; BILIOPANCREATIC BYPASS; BLEEDING; CONSTIPATION; DIARRHEA; FECES INCONTINENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PREVALENCE; WOUND HEALING;

EID: 84858608542     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i10.1021     Document Type: Article

References (35)

1. Bennett JM, Mehta S, Rhodes M. Surgery for morbid obesity. Postgrad Med J 2007; 83: 8-15.
2. Fobi MA. Surgical treatment of obesity: a review. J Natl Med Assoc 2004; 96: 61-75.
3. Dixon JB. Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes. World J Surg 2009; 33: 2014-2021.
4. Simard B, Turcotte H, Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Boulet LP. Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004; 14: 1381-1388.
5. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA 2005; 294: 1918-1924.
6. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
7. Livingston EH. Obesity, mortality, and bariatric surgery death rates. JAMA 2007; 298: 2406-2408.
8. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.
9. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075-1079.
10. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956-961.
11. Van Hee RH. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg 2004; 28: 435-444.
12. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. Biliopancreatic diversion. World J Surg 1998; 22: 936-946.
13. Scopinaro N, Marinari G, Camerini G, Papadia F. Biliopancreatic diversion for obesity: state of the art. Surg Obes Relat Dis 2005; 1: 317-328.
14. Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci 2010; 55: 2606-2613.
15. Potoczna N, Harfmann S, Steffen R, Briggs R, Bieri N, Horber FF. Bowel habits after bariatric surgery. Obes Surg 2008; 18: 1287-1296.
16. Wasserberg N, Hamoui N, Petrone P, Crookes PF, Kaufman HS. Bowel habits after gastric bypass versus the duodenal switch operation. Obes Surg 2008; 18: 1563-1566.
17. Marinari GM, Papadia FS, Briatore L, Adami G, Scopinaro N. Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. Obes Surg 2006; 16: 1440-1444.
18. Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999; 341: 65-69.
19. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998; 338: 217-220.
20. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356: 2176-2183.
21. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Longterm mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761.
22. Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol 1990; 12: 505-512.
23. Chen CC, Gatmaitan P, Koepp S, Barber MD, Chand B, Schauer PR, Brethauer SA. Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis 2009; 5: 411-415.
24. Lawrence JM, Lukacz ES, Liu IL, Nager CW, Luber KM. Pelvic floor disorders, diabetes, and obesity in women: findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study. Diabetes Care 2007; 30: 2536-2541.
25. Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 2008; 111: 678-685.
26. Shamliyan T, Wyman J, Bliss DZ, Kane RL, Wilt TJ. Prevention of urinary and fecal incontinence in adults. Evid Rep Technol Assess (Full Rep) 2007; 1-379.
27. Wasserberg N, Haney M, Petrone P, Ritter M, Emami C, Rosca J, Siegmund K, Kaufman HS. Morbid obesity adversely impacts pelvic floor function in females seeking attention for weight loss surgery. Dis Colon Rectum 2007; 50: 2096-2103.
28. Crea N, Pata G, Di Betta E, Greco F, Casella C, Vilardi A, Mittempergher F. Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity. Obes Surg 2011; 21: 139-145.
29. Crookes PF. Surgical treatment of morbid obesity. Annu Rev Med 2006; 57: 243-264.
30. Z'graggen K, Guweidhi A, Steffen R, Potoczna N, Biral R, Walther F, Komminoth P, Horber F. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 2008; 18: 981-988.
31. Lindsey I, Jones OM, Cunningham C, Mortensen NJ. Chronic anal fissure. Br J Surg 2004; 91: 270-279.
32. Elía Guedea M, Gracia Solanas JA, Royo Dachary P, Ramírez Rodríguez JM, Aguilella Diago V, Martínez Díez M. Prevalence of anal diseases after Scopinaro's biliopancreatic bypass for super-obese patients. Cir Esp 2008; 84: 132-137.
33. Brisinda G, Vanella S. Chronic anal fissure: Surgical or reversible neurochemical sphincterotomy? Nat Rev Gastroenterol Hepatol 2009; 6: 694-695.
34. Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg 2007; 94: 162-167.
35. Brisinda G, Albanese A, Cadeddu F, Bentivoglio AR, Mabisombi A, Marniga G, Maria G. Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial. Aliment Pharmacol Ther 2004; 19: 695-701